Manchester University NHS Foundation Trust - North Manchester General Hospital

The Manchester University NHS Foundation Trust - North Manchester General Hospital incorporates North Manchester General Hospital which was reported as part of Pennine Acute Hospitals NHS Trust up to and including 2019-20 https://mft.nhs.uk//

For 2022-2023 outcomes, Manchester Royal Infirmary, Wythenshawe Hospital and North Manchester General Hospital are reporting under the Manchester University NHS Foundation Trust

View latest outcomes

View Trust Services

This trust offers the following services:

  • Acute services:
    • On-site bowel stenting facilities
  • Diagnostic and pre-operative services:
    • On-site PET-CT facilities
    • On-site Cardio-Pulmonary Exercise Testing (CPET) facilities
    • Age Specific Genetic Testing for Lynch Syndrome
  • Surgical services:
    • On-site hepatobiliary surgical team
    • On-site thoracic surgical team
    • Robotic surgery
  • Advanced disease services:
    • Dedicated Specialist Advanced MDT
    • Complex vascular reconstruction
    • Distal sacrectomy
    • High sacrectomy
    • Extended lymphadenectomy
  • Support service facilities:
    • Dedicated nurses for ERAS services
    • Availability of 24 hour palliative care advice
    • 7-day access to face-to-face palliative care services

Data Quality
All Patients: Trust Network National
Number of patients in Audit 110 1862 35779
Case ascertainment (%) Good Good Good
Data completeness of:
– Pre-treatment TNM (%) 85 87 86
– Performance status (%) 95 89 89
Patients having major resection: Trust Network National
Number of patients in Audit N/A 994 19631
ASA grade 1 (%) N/A 16 9
ASA grade 2 (%) N/A 44 53
ASA grade 3 (%) N/A 36 31
ASA grade 4+ (%) N/A 2 2
ASA grade not recorded (%) N/A 2 4
Data completeness of:
7 Audit items for risk-adjustment (%) N/A 95 87

Key:

> 80%
50 - 80%
< 50%

Management of all patients
All Patients: Trust Network National
Number of patients in Audit 110 1862 35779
Seen by Clinical Nurse Specialist (%) 99 92 88

Management of patients having major resection
Patients having major resection: Trust Network National
Number of patients in Audit N/A 994 19614
Distant metastases (%) N/A 4 5
Urgent or emergency surgery (%) N/A 12 15
At least 12 lymph nodes excised (%) N/A 89 84
Laparoscopic surgery attempted (%) N/A 63 72
Risk-adjusted length of stay > 5 days (%) N/A 60 55
Patients having major resection for stage III colon cancer: Trust Network National
Number of patients in audit 46 N/A 10747
Adjuvant chemotherapy (%) 46 N/A 62
Patients receiving chemotherapy after major resection for stage III colon cancer: Trust Network National
Number of patients in audit N/A N/A 6608
Severe acute toxicity after adjuvant chemotherapy (%) N/A N/A 22

Rectal cancer patients
Patients having major resection: Trust Network National
Number of patients in Audit N/A N/A 4251
Neoadjuvant therapy (%) N/A N/A 33
Circumferential resection margin: Recorded (%) N/A 96 89
Circumferential resection margin: Negative (%) N/A 89 83
Rectal volume N/A N/A 4377
Patients in APER/Hartmanns estimate: Trust Network National
Number of patients in APER/Hartmanns estimate 108 809 19644
APER/Hartmanns (%) 34 43 37

Compare trust outcomes

Copyright © 2025 National Bowel Cancer Audit | Lovingly Crafted by Mixd